Noom Debuts Microdose GLP-1 Program to Help Reduce Side Effects and Boost Affordability Nicholas Saraceno, Senior Editor Key Takeaways Noom's Microdose GLP-1Rx Program offers personalized microdoses to reduce side effects and improve affordability, addressing high obesity rates and cost disparities in the US
reported that obese rats exhibited increased TNF- levels alongside reduced bone volume, trabecular number, and cortical thickness
PMID: 19043625
Current approved peptides have generally demonstrated favorable safety profiles, with most adverse effects being manageable and reversible
Taking the Next Step If youve felt stuck between diet culture extremes and pharmaceutical fasttracks, the benefits of microdosing semaglutide offer a middle pathone that respects your hormones, mental health, and longterm goals
If a patient discontinued medication in a bin, they would not be included in the next bin